STAA vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

STAA

47.1
AI Score
VS
STAA Wins

XRAY

43.0
AI Score

Investment Advisor Scores

STAA

47score
Recommendation
HOLD

XRAY

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric STAA XRAY Winner
Revenue 2.61B 113.12M XRAY
Net Income 25.00M 13.56M XRAY
Gross Margin 52.1% 78.1% STAA
Net Margin 1.0% 12.0% STAA
Operating Income 84.00M 18.12M XRAY
ROE 1.8% 5.8% STAA
ROA 0.5% 4.6% STAA
Total Assets 5.19B 294.44M XRAY
Cash 195.00M 173.08M XRAY
Current Ratio 1.63 5.94 STAA

Relative Price Performance (Last 90 Days)

STAA 1M: +22.6% · 3M: +2.3% XRAY 1M: +9.5% · 3M: -20.3%

Current Technical Phase

STAA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.7% over 20 days), RSI 63

RSI (14): 62.7 · Price: $26.78

XRAY

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.3%) with fading momentum, RSI 46

RSI (14): 45.9 · Price: $9.24

Fundamentals Snapshot

Metric STAA XRAY
Market Cap — —
Forward P/E 23.2 7.4
Trailing P/E 2669.0 —
Revenue (TTM) — —
Revenue Growth -0.1% -0.1%
Gross Margin 0.7% 0.5%
Operating Margin 0.1% 0.0%
EPS 0.01 -0.61
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, STAA is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.